Dr Agarwals Eye Hospital Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is 22.20% vs 25.23% in Dec 2024

Standalone Net Profit

YoY Growth in quarter ended Dec 2025 is 66.15% vs 10.17% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 34.15% vs 23.35% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is -47.27% vs 110.38% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Dr Agarwal's Eye With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

116.22

371.61

-255.39

-68.73%

Other Operating Income

0.00

Total Operating income

116.22

371.61

-255.39

-68.73%

Raw Material Cost

0.00

63.75

-63.75

-100.00%

Purchase of Finished goods

11.98

0.00

11.98

(Increase) / Decrease In Stocks

-0.26

0.00

-0.26

Employee Cost

24.10

74.89

-50.79

-67.82%

Power Cost

0.00

Manufacturing Expenses

29.15

95.46

-66.31

-69.46%

Selling and Distribution Expenses

0.00

Other Expenses

16.88

75.56

-58.68

-77.66%

Total Expenditure (Excl Depreciation)

81.85

309.66

-227.81

-73.57%

Operating Profit (PBDIT) excl Other Income

34.37

61.95

-27.58

-44.52%

Other Income

2.77

7.15

-4.38

-61.26%

Operating Profit (PBDIT)

37.14

69.10

-31.96

-46.25%

Interest

2.03

1.46

0.57

39.04%

Exceptional Items

0.00

Gross Profit (PBDT)

35.11

67.64

-32.53

-48.09%

Depreciation

11.66

11.25

0.41

3.64%

Profit Before Tax

23.45

56.39

-32.94

-58.41%

Tax

6.17

15.39

-9.22

-59.91%

Provisions and contingencies

0.00

Profit After Tax

17.28

41.00

-23.72

-57.85%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

17.28

41.00

-23.72

-57.85%

Equity Capital

4.83

91.67

-86.84

-94.73%

Face Value

10.00

0.00

Reserves

0.00

Earnings per share (EPS)

35.78

4.47

31.31

700.45%

Diluted Earnings per share

35.76

4.47

31.29

700.00%

Operating Profit Margin (Excl OI)

29.57%

16.67%

0.00

12.90%

Gross Profit Margin

30.21%

18.20%

0.00

12.01%

PAT Margin

14.87%

11.03%

0.00

3.84%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 116.22 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -1.27% vs 0.68% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 22.20% vs 25.23% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 17.28 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -10.56% vs 11.94% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 66.15% vs 10.17% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 34.37 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -14.25% vs 7.95% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 34.15% vs 23.35% in Dec 2024

Quarterly - Interest

Interest 2.03 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -45.58% vs -10.34% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -47.27% vs 110.38% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 29.57%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024